AT1 3.23% 3.0¢ atomo diagnostics limited

Media Update, page-6

  1. 1,563 Posts.
    lightbulb Created with Sketch. 141
    Access Bio,'Surge' in US Approval of Corona 19 Antigen Diagnosis Kit

    Han Soo-yeon

    Input 2020.10.12 09:19

    Revision 2020.10.12 09:19

    comment 0dog

    Accessbio surged as it obtained emergency use approval (EUA) from the US Food and Drug Administration (FDA) for a rapid diagnosis kit for the novel coronavirus infection (Corona 19) antigen.

    As of 9:15 am on the 12th, Access Bio in the KOSDAQ market is trading at 34,000 won, up 25.69% (6,950 won) compared to the previous trading day.

    On the 10th, Accessbio announced on the 10th that its Corona 19 antigen rapid diagnosis kit'CareStart™ COVID-19 Antigen' has obtained emergency approval from the US FDA. This kit is a product that can quickly diagnose the presence of corona infection within 10 to 15 minutes by collecting a patient's sample from the nasopharynx and immunochromatography.


    This new looks very positive to me : ) . just waiting on the approval of CareStart COVID-19 IgM/IgG. lol
 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
(20min delay)
Last
3.0¢
Change
-0.001(3.23%)
Mkt cap ! $19.17M
Open High Low Value Volume
2.9¢ 3.0¢ 2.9¢ $6.847K 236.1K

Buyers (Bids)

No. Vol. Price($)
2 337607 2.9¢
 

Sellers (Offers)

Price($) Vol. No.
3.0¢ 47765 2
View Market Depth
Last trade - 16.10pm 07/05/2024 (20 minute delay) ?
Last
2.9¢
  Change
-0.001 ( 6.45 %)
Open High Low Volume
2.9¢ 3.0¢ 2.8¢ 52849
Last updated 15.24pm 07/05/2024 ?
AT1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.